KSANF(KSANF)
KSANF
No analyst ratings available
No analyst price targets available for KSANF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $654.00B | $665.56B | $689.91B | $695.76B | $712.75B |
| Low | $644.14B | $623.15B | $662.53B | $668.15B | $684.47B |
| High | $665.12B | $703.90B | $715.81B | $721.88B | $739.51B |
| EBITDA Avg | $94.49B | $96.16B | $99.68B | $100.52B | $102.98B |
| Low | $93.06B | $90.03B | $95.72B | $96.53B | $98.89B |
| High | $96.10B | $101.70B | $103.42B | $104.30B | $106.84B |
| EBIT Avg | $72.08B | $73.36B | $76.04B | $76.69B | $78.56B |
| Low | $71.00B | $68.68B | $73.02B | $73.64B | $75.44B |
| High | $73.31B | $77.58B | $78.90B | $79.56B | $81.51B |
| Net Income Avg | $31.68B | $44.45B | $50.30B | $51.50B | $53.92B |
| Low | $30.05B | $42.15B | $47.71B | $48.84B | $51.14B |
| High | $33.23B | $46.61B | $52.76B | $54.01B | $56.56B |
| EPS Avg | $148.63 | $208.51 | $236.00 | $241.60 | $252.98 |
| Low | $140.96 | $197.75 | $223.82 | $229.13 | $239.93 |
| High | $155.88 | $218.69 | $247.52 | $253.39 | $265.33 |
| Analysts (Rev / EPS) | 3 / 1 | 8 / 1 | 4 / 1 | 4 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $162.84B | $172.30B | $160.31B | $183.62B | $172.19B | $178.21B | $155.86B | $191.38B |
| Low | $162.84B | $172.30B | $160.31B | $183.62B | $172.19B | $178.21B | $155.86B | $191.38B |
| High | $162.84B | $172.30B | $160.31B | $183.62B | $172.19B | $178.21B | $155.86B | $191.38B |
| EBITDA Avg | $23.53B | $24.89B | $23.16B | $26.53B | $24.88B | $25.75B | $22.52B | $27.65B |
| Low | $23.53B | $24.89B | $23.16B | $26.53B | $24.88B | $25.75B | $22.52B | $27.65B |
| High | $23.53B | $24.89B | $23.16B | $26.53B | $24.88B | $25.75B | $22.52B | $27.65B |
| EBIT Avg | $17.95B | $18.99B | $17.67B | $20.24B | $18.98B | $19.64B | $17.18B | $21.09B |
| Low | $17.95B | $18.99B | $17.67B | $20.24B | $18.98B | $19.64B | $17.18B | $21.09B |
| High | $17.95B | $18.99B | $17.67B | $20.24B | $18.98B | $19.64B | $17.18B | $21.09B |
| Net Income Avg | $5.10B | $11.23B | $-1.13B | $10.86B | $8.00B | $10.60B | $1.28B | $12.01B |
| Low | $5.10B | $11.23B | $-1.13B | $10.86B | $8.00B | $10.60B | $1.28B | $12.01B |
| High | $5.10B | $11.23B | $-1.13B | $10.86B | $8.00B | $10.60B | $1.28B | $12.01B |
| EPS Avg | $23.84 | $52.48 | $-5.28 | $50.73 | $37.37 | $49.52 | $6.00 | $56.11 |
| Low | $23.84 | $52.48 | $-5.28 | $50.73 | $37.37 | $49.52 | $6.00 | $56.11 |
| High | $23.84 | $52.48 | $-5.28 | $50.73 | $37.37 | $49.52 | $6.00 | $56.11 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |